Clinical Trials Directory

Trials / Completed

CompletedNCT01331382

Cerebral Blood Flow Effects of Resveratrol and Piperine in Humans

Effects of Resveratrol Alone or in Combination With Piperine on Cerebral Blood Flow Parameters and Cognitive Performance in Humans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Northumbria University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Resveratrol is associated with a plethora of physiological effects in humans, including modulation of cerebral blood flow, despite apparently poor bioavailability. This study investigated whether the physiological effects of resveratrol could be affected when co-supplemented with piperine, an alkaloid which may be able to enhance the bioavailability of resveratrol.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTrans- resveratrolAll 23 participants who completed the study took part in 3 conditions; receiving either 250mg resveratrol, 250mg resveratrol with 20mg piperine or placebo on separate days (with a 48hr-14 day wash-out period between each treatment) with the order dictated by Latin square. Treatment was in the form of powder and administered in capsule form, in a double blind manner.
OTHERPlacebo (silica)All 23 participants who completed the study took part in 3 conditions; receiving either 250mg resveratrol, 250mg resveratrol with 20mg piperine or placebo on separate days (with a 48hr-14 day wash-out period between each treatment) with the order dictated by Latin square. Treatment was in the form of powder and administered in capsule form, in a double blind manner.

Timeline

Start date
2010-04-01
Primary completion
2010-11-01
Completion
2010-11-01
First posted
2011-04-08
Last updated
2011-04-08

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01331382. Inclusion in this directory is not an endorsement.